Showing results (2361-2370 of 3,086) with videos related to
Sort By:
Pageof 309
Drug Safety|July 31, 2021
Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and PrinciplesNoha Iessa, Viola Macolic Sarinic, Lilit Ghazaryan, et al.Drug Safety|July 5, 2022
Pancreas and Adverse Drug Reactions: A Literature ReviewKonrad Sosnowski, Piotr Nehring, Adam PrzybyłkowskiDrug Safety|June 23, 2022
Signaling COVID-19 Vaccine Adverse EventsRave Harpaz, William DuMouchel, Robbert Van Manen, et al.Drug Safety|October 30, 2020
Proposals for Engaging Patients and Healthcare Professionals in Risk Minimisation from an Analysis of Stakeholder Input to the EU Valproate Assessment Using the Novel Analysing Stakeholder Safety Engagement Tool (ASSET)Priya Bahri, Daniel R Morales, Adrien Inoubli, et al.Drug Safety|June 10, 2017
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence MappingIppazio Cosimo Antonazzo, Emanuel Raschi, Luca Vignatelli, et al.Drug Safety|October 25, 2021
Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza SeasonIgnacio Salamanca de la Cueva, Elisa Cinconze, Tamara Eckermann, et al.Drug Safety|October 5, 2021
Maternal Complications and Prescription Opioid Exposure During Pregnancy: Using Marginal Structural ModelsXuerong Wen, Shuang Wang, Adam K Lewkowitz, et al.Drug Safety|October 6, 2021
Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification SystemsPierre-Olivier Blotière, Christine Damase-Michel, Alain Weill, et al.Drug Safety|October 8, 2021
An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster VaccinePaola Pirrotta, Fernanda Tavares-Da-Silva, Maribel Co, et al.Drug Safety|October 4, 2021
Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary ToxicityNaomi T Jessurun, Marjolein Drent, Petal A Wijnen, et al.Pageof 309